A couple has been trying for eighteen months. She has had her cycle mapped, hormones drawn across multiple phases, a pelvic ultrasound, an AMH, a thyroid panel, possibly a hysterosalpingogram, possibly a laparoscopy. He has had a conversation. Maybe.

Male factor accounts for somewhere in the range of 40-50% of infertility, either as the primary contributor or as half of a combined picture. A semen analysis costs a fraction of what any of the above costs, takes one sample, and is non-invasive in the most literal sense. The order of operations in most of these workups is backwards, and it stays backwards for reasons that have very little to do with clinical reasoning.

Before you begin

Is this for you?

This guide is for

Men actively trying to conceive, or planning to within the next one to three years
Men with a sub-reference semen analysis, an elevated FSH, a low testosterone, or an unexplained result nobody has walked them through
Men currently on testosterone replacement who want children - this guide is written with you specifically in mind
Men who want to understand their own reproductive physiology well enough to ask better questions, whether or not conception is imminent

This guide is not

A replacement for fertility urology where the analysis is abnormal or a structural cause is suspected
A reason to stop a prescribed medication on your own. Nothing here is an instruction to change what a prescriber has you on

Context

The other half of the equation

The female guide covers the ovarian, cyclical, and endometrial architecture, and it does not translate to a male-factor workup. That said, as a partner, you should read both. The practical overlap is larger than differences: omega-3s, CoQ10, methylation status, glycemic control, sleep, and inflammatory load move both partners' parameters, and the cellular levers are not gendered even where the anatomy is.

A distinct part that belongs here is your age. It gets a fraction of the coverage maternal age gets, and it operates through a mechanistically distinct route - de novo mutation rate rises with paternal age because spermatogonial stem cells keep dividing across a lifetime and accumulate copying errors, where oocyte aging is a story about a fixed stock degrading. Different mechanism, different curve, and it shows up in outcomes that have nothing to do with whether conception happens.

The mechanism

The biological foundation

Sperm production is a manufacturing line, and the line runs on a fixed schedule. Spermatogonial stem cells sit against the basement membrane of the seminiferous tubule and divide continuously - unlike the female stock, which was finalized before birth. A cell entering the process takes roughly 64 to 74 days to become a spermatozoon, and then another 10 to 14 days transiting the epididymis, where it acquires motility and the capacity to fertilize.

Two cell populations do the supporting work. Sertoli cells line the tubule, form the blood-testis barrier, and nurse each developing cohort through the sequence - FSH is the pituitary signal that speaks to them. Leydig cells sit outside the tubules in the interstitium and make testosterone in response to LH. Those two signals have completely different jobs, which is why it's important to read them in concert.

The concentration of testosterone inside the testis runs on the order of a hundred times what circulates in blood. Spermatogenesis depends on the intratesticular concentration specifically, and a serum testosterone in the normal range tells you very little about whether the tubule is getting what it needs.

Timing

The seventy-four day window

Everything you do today shows up in a sample taken three months from now.

This single fact shapes the entire approach. The batch being ejaculated this week entered production three months ago - it carries whatever oxidative load, thermal exposure, nicotine, cannabis, sleep debt, and micronutrient status was present then. Change something today and the sample in six weeks will be a blend of old batch and new. The clean read is at three months.

Two practical consequences follow. The first is that a bad result has a shelf life. A fever, a hot-tub habit, a stretch of terrible sleep, a course of illness - any of these can drop a count substantially, and the drop is not a verdict on the man's fertility. It is a snapshot of a window that has already closed. A sub-optimal result deserves a repeat at two to three months before anyone builds a plan on it.

The second is that the timeline for intervention is fixed and non-negotiable. Starting CoQ10 four weeks before an IVF cycle is starting it too late. If conception is on the horizon, the protocol warrants a start at least three months out. That is the length of the production cycle, plain and simple.

Reading the panel

What FSH and LH tell you that testosterone cannot

The panel worth running is FSH, LH, total and free testosterone, SHBG, estradiol, prolactin, and a full thyroid panel. What makes it informative is the relationship between the first three.

Elevated FSH and LH alongside a low testosterone is a primary picture - the pituitary is shouting and the testes are not answering. The signal is being sent correctly and the tissue receiving it is underperforming. Elevated FSH specifically points at spermatogenic stress, because FSH is the Sertoli-cell signal and the Sertoli cells are the ones nursing the cohort.

Low-to-normal LH and FSH alongside a low testosterone is a secondary picture, and it is a different problem entirely - the signal is not being sent in the first place. The testes may be perfectly capable. Head injury, opioid use, psychotropic medication, severe metabolic dysfunction, and pituitary lesions all live on this branch, as does a chronically elevated prolactin, which suppresses GnRH upstream of everything.

Same two markers. Opposite conclusions. Opposite interventions.

Estradiol is a marker that is generally confused amongst men. Men need estradiol - it is doing critical work in bone, brain, endothelium, and libido - and driving it down is not a fertility strategy. At the same time, excess estradiol, usually from aromatization in fat tissue, does suppress the gonadal axis and impair sperm quality. The lever to pull for that is body composition, not suppressing your estradiol.

SHBG deserves a line of its own because it distorts the reading. It binds testosterone out of circulation, so a high SHBG can produce a normal total testosterone sitting on top of a low free fraction. Where the total looks fine and the clinical picture does not, free testosterone and SHBG can usually help resolve it.

Thyroid closes the panel, and TSH on its own does not cover it. TSH is the pituitary's message about thyroid status rather than a measure of what the tissue is receiving, so the panel worth running is TSH together with free T4, free T3, reverse T3, and thyroid antibodies. The free hormones show whether it is actually there and whether T4 is converting to the active form; antibodies can be positive while TSH still reads normal, which is autoimmunity underway before the number has moved.

Reverse T3 is the inactive form T4 can be diverted into instead of active T3, and a raised one usually corroborates a picture of inflammation or physiological stress rather than pointing at the thyroid itself. That same inflammatory and stress burden compounds the fertility picture by its own routes - oxidative damage to sperm DNA, suppression higher up the axis, and the sleep and metabolic layers further down this guide.

Both directions of thyroid dysfunction reach this axis, and they arrive by different routes. An underactive thyroid tends to raise prolactin, and prolactin suppresses GnRH upstream of everything - the same branch the secondary picture above sits on. An overactive one raises SHBG, which binds testosterone out of circulation exactly as described a paragraph ago, and impairs motility in its own right. Thyroid hormone also acts on the Sertoli cells directly, which is the tissue nursing each developing cohort.

A TSH above about 2.5 mIU/L is worth addressing, and it is cheap to correct relative to what it costs to leave alone.

The section that matters most

The testosterone trap

This is the one most likely to be read as an ultimatum. It is not one. Read it to the end before deciding anything.

Exogenous testosterone suppresses sperm production. The mechanism is straightforward: replacement doses provide the negative feedback the hypothalamus and pituitary are watching for, LH output falls, and the Leydig cells - which only make testosterone when LH tells them to - go quiet. Serum testosterone looks great, because it is being supplied from outside. Intratesticular testosterone collapses, because nothing is producing it locally. And intratesticular testosterone is what spermatogenesis runs on.

The result is a man with an excellent testosterone level on paper and a semen analysis that has fallen off a cliff. Somewhere between a substantial fraction and effectively all of production can shut down, depending on dose, duration, and the individual.

This is not a low testosterone problem, and treating it as one inverts it. The Low T picture is a man whose testosterone is low and needs raising. This man's serum testosterone is normal or frankly high - because he is taking it - and that is precisely the trouble. He does not need more testosterone. He needs testicular function back, which is the opposite intervention wearing an almost identical lab picture.

The two present the same way on a basic panel: low LH, low FSH. The read that separates them is what sits beside those gonadotropins.

Low LH and FSH beside a high or normal testosterone - exogenous suppression. Something is being taken.
Low LH and FSH beside a low testosterone - secondary hypogonadism. The signal is not being sent at all.

Read the gonadotropins, not the testosterone.

Now the part that actually matters to a man reading this and feeling cornered. The restart is a managed sequence, not a cliff. The shape of it - and the specifics belong to a prescriber, not to a guide - is that replacement comes down, a SERM such as enclomiphene blocks the estrogen feedback at the hypothalamus so the gonadotropins climb back, intratesticular testosterone recovers, and spermatogenesis resumes over the following months. hCG works as an LH mimetic on the same problem from a different angle. In the protocols I have seen work, a low dose of exogenous testosterone often runs underneath the whole transition, specifically so the man does not spend six months feeling terrible while his axis comes back.

That last detail is why the absolute version of this rule - never testosterone if you want children - is wrong, and why I will not write it. The protocol that restores fertility frequently contains testosterone. The claim is not that testosterone is forbidden; it is that replacement dosing, unaccompanied, is the wrong lever for this goal.

If you are on testosterone and you want children, the conversation to have with your prescriber is about sequence and timing, not about whether you are allowed. Men decline ultimatums about how they feel every day, and a man who reads this as "stop your testosterone and suffer" will simply never raise it. That outcome is worse than every clinical risk on this page.

Recovery is usually good and it is not universal. Longer duration of use, higher doses, and older age all lengthen the timeline, and a minority of men do not return to baseline. Where fertility is on the horizon, having the conversation before starting replacement is worth considerably more than having it afterward.

The outcome measure

The semen analysis

Hormones hint. The semen analysis tells you.

WHO 2021 lower reference limits

Volume 1.4 mL Concentration 16 M/mL Total count 39 M Total motility 42% Progressive motility 30% Normal morphology 4% Vitality 54%

Those numbers require a caveat that changes how you read them. They are fifth-centile values derived from men whose partners conceived within twelve months - they describe the bottom edge of a fertile population, not a boundary between fertile and infertile. Men below them conceive. Men comfortably above them struggle. Treat a sub-reference result as information about probability and about which lever to pull, not as a verdict.

Morphology is the parameter that alarms people most and deserves it least in isolation. A 4% normal-forms threshold sounds catastrophic until you know that strict Kruger criteria score almost everything as abnormal by design. Read it alongside count and motility rather than on its own.

Two additions are worth requesting when the standard panel looks unremarkable and conception still is not happening. DNA fragmentation index measures the integrity of the genetic payload rather than the appearance or movement of the cell - a man can have a textbook analysis and a high fragmentation index, and it associates with miscarriage and failed fertilization more than with failure to conceive. Thresholds vary by assay, so interpret it with the lab that ran it. Oxidative stress panels cover related ground.

At-home collection kits have made the first analysis considerably easier to actually obtain, which matters more than it sounds like it should - the analysis that never gets done is the failure mode I run into most often in this workup. Confirm anything abnormal with a repeat at two to three months.

Modifiable inputs

The environmental layer

Three levers here, and the first is the highest-return free intervention in this guide.

Fastest lever

Heat

The testes sit outside the body because spermatogenesis requires a temperature a few degrees below core. That arrangement is not incidental and it is easy to defeat. Hot tubs, saunas, heated seats, a laptop resting on the lap, tight underwear, and long unsupported cycling all raise scrotal temperature enough to matter. A febrile illness or a regular hot-tub habit can drop a count for the better part of three months. Removing the heat source costs nothing and the effect is among the fastest available.

Three-month window

Substances

Nicotine, cannabis, and heavy alcohol each degrade count, motility, and morphology. Cannabis has a mechanism worth naming specifically: sperm carry cannabinoid receptors, and endocannabinoid signaling is involved in motility and in the acrosome reaction, so THC acts on the cell directly rather than only through the axis. Recovery takes a production cycle, which puts the useful cessation window at three months or more before trying. Antioxidant cover through that window is reasonable.

Runs against intuition

Frequency

The common advice is to save up before the fertile window. Semen quality degrades after roughly two to three days of abstinence - motility and DNA integrity both fall as sperm sit in the epididymis accumulating oxidative exposure - so the saved-up sample is a larger volume of worse sperm. Intercourse every one to two days through the fertile window produces better parameters and better pregnancy rates than strategic abstinence does.

Upstream of the panel

The metabolic layer

Body composition is upstream of the hormone panel, and it acts through two routes at once. Adipose tissue expresses aromatase, which converts testosterone to estradiol - so excess fat mass lowers testosterone and raises estradiol simultaneously, from a single mechanism. Separately, insulin resistance raises oxidative stress in the testis and impairs steroidogenesis directly. Fasting insulin and HbA1c belong on the panel for this reason, not as general-health box-ticking.

Sleep is the lever men consistently underweight. The majority of daily testosterone production happens during sleep, tied to the overnight LH pulses - which means short or fragmented sleep is not a background lifestyle variable here, it is a direct hit on the signal driving both testosterone and spermatogenesis. Seven hours, consistent timing. If sleep is the limiting factor, the sleep guide is the more useful document than this one.

The other half

Biopsychosocial fitness

Everything to this point has been anatomy and physiology, which is the half of male reproductive fitness that gets written about. The other half runs through the nervous system, and it is harder to put on a page because it does not reduce to a marker you can draw.

Begin with what testosterone is for. The axis is not a thermostat holding a set point - it is appraising circumstance and setting output to match. Production responds to sleep, to training load, to nutritional state, to whether challenge is being met, and to standing among other men. Read that way, a low number is often the body's appraisal of the position a man is in rather than a fault in the testes, which is the reason the men whose numbers move furthest on a protocol are usually the ones whose circumstances moved with them.

This is not an argument against replacement, and it is not a claim that circumstance explains every low testosterone - primary testicular failure is real and the panel above is how you find it. It is an argument for reading the number as information before treating it as a deficit.

The developmental literature makes the same point from the other end. Age at first intercourse turns out to predict a range of long-term personal and relational outcomes, and the direction is the opposite of what a purely reproductive account would predict: earlier is associated with worse, not better. The association is not mostly a story about the act itself. Mendelian randomization and genome-wide work point to shared genetic architecture - variants in dopamine signaling, cell migration, and estrogen signaling that associate with earlier debut and, independently, with risk tolerance and impulsivity. The same underlying temperament produces both, which is why treating the timing as the cause misreads the finding.

What sits underneath is a trade between horizons. Reward systems weighted toward novelty and immediacy tend to spend effort where it returns fastest; systems weighted toward delay accumulate the slower goods - skill, standing, a partner who stays. Sexual selection is the engine that historically pointed male effort at the second column. Most of what a young man builds, he builds to become selectable, whether or not he would put it that way.

So what happens to that effort when the signal organizing it weakens?

~ The problem of fatherlessness is real, and the point of asking is not to moralize about it. Understanding the motivation underneath wanting children is what makes the unforeseen parts survivable. As Nietzsche put it, he who has a why can bear almost any how. ~

Pornography, short-form video, delivery food, alcohol, nicotine - the common framing treats these as failures of discipline. They are better understood as working exactly as designed. Each delivers a reward that historically required effort, courtship, or scarcity, and delivers it faster and more reliably than the thing it stands in for. That is not weakness. It is a reward system meeting a stimulus it was never calibrated against, and the same architecture that makes a man persist through a hard year is the one being satisfied on a shorter loop.

For fertility specifically, the part that carries mechanism rather than commentary is narrow. Alcohol and nicotine have direct effects on the parameters, and they are covered above. Sleep displaced by late screens hits the overnight LH pulses. Chronic novelty-seeking that crowds out training, daylight, and food quality reaches the axis through routes this guide has already named. Beyond that, the honest position is that the literature connecting these behaviors to semen parameters is thin, and I am not going to build a mechanism where the evidence has not.

If the panel is unremarkable, the analysis is unremarkable, and conception still is not happening, the question worth sitting with is whether the conditions the axis is appraising have changed - and whether the effort that used to go somewhere is currently going anywhere.

The findable cause

The structural layer

Varicocele is the most common surgically correctable cause of male infertility - dilated veins in the pampiniform plexus impairing venous drainage, raising scrotal temperature, and increasing oxidative stress. It is present in a meaningful minority of men with abnormal parameters, and repair improves semen parameters in appropriately selected cases. Whether repair is indicated is a fertility-urology conversation, and it is worth having where the analysis is abnormal.

Not every varicocele needs repairing, and the literature on who benefits is more contested than the surgical enthusiasm suggests. The reason it is here is that it is common, findable on examination or ultrasound, and one of the few structural contributors on this list rather than a physiological one.

A testicular lesion described on imaging is a different category and warrants prompt urology follow-up on its own terms, independent of the fertility picture.

The stack

The protocol

Everything below is available through the practitioner dispensary: Fullscript

We do receive commission on sales from this link - if you found this helpful, please support.

Bring this list, your semen analysis, and your labs to a provider before starting. Several items interact with medications and several are dose-sensitive to your tested values rather than to a generic recommendation.

Start with the foundation. Targeted additions work considerably better in a system that has been brought to nutritional sufficiency, and several of the targeted items are already inside a good combination product - check the label before stacking.

Foundation

Comprehensive male fertility blendas directed

A sperm-targeted multi covering zinc, selenium, CoQ10, carnitine, antioxidants, and folate in one product. This is the platform the rest sits on.

Omega-3, DHA-forward2-4 g/day, with food

Combined EPA and DHA. The sperm membrane is enriched in DHA, and omega-3 status tracks with motility and morphology.

Vitamin D3 with K2 (MK-7)dosed to 40-60 ng/mL

Often around 5,000 IU/day. Vitamin D receptors are expressed in the testis and on sperm itself. The reproductive target sits above the standard deficiency cutoff, so test rather than guess - most men taking 1,000-2,000 IU do not reach it.

L-5-MTHF (methylfolate)1 mg daily

Higher with a known MTHFR variant, which is a conversation to have. Sperm DNA methylation depends on active folate, and homozygous MTHFR 677TT is over-represented in male infertility. Pairs with B12.

Targeted

CoQ10 as ubiquinol200 mg/day

Started at least three months out. The sperm midpiece is dense with mitochondria, and motility is an energy problem.

Acetyl-L-carnitine1,000 mg/day

Shuttles fatty acids into sperm mitochondria; a motility-specific lever that pairs with CoQ10.

N-Acetyl Cysteine600 mg/day

Glutathione precursor supporting the antioxidant system that protects sperm DNA, and it helps semen viscosity. Most relevant where oxidative or inflammatory load is part of the picture.

Zinc with copper bisglycinatezinc 30-60 mg/day

With copper to balance. Zinc is rate-limiting for sperm production, count, morphology, and DNA stability. Long-term zinc without copper drives a copper deficiency, so keep them paired - and do not stack this on a blend that already contains both.

Vitamin C1,000 mg/day

Water-phase antioxidant concentrated in seminal plasma; cheap cover through a nicotine or cannabis cessation window specifically.

Melatonin1-3 mg nightly

A potent antioxidant present in the testes, and it doubles as the sleep lever, which is itself moving testosterone.

Macaone capsule twice daily

A reproductive adaptogen supporting HPG coordination and libido under load.

RevolutionPRO · male formulation

What to track

What to track, and when

The retest window is three months, because that is the production cycle. Judging progress by feel inside that window will mislead you in both directions.

The outcome measure

Semen analysis - repeat at 2-3 months

The axis, at twelve weeks

FSH LH Total testosterone Free testosterone SHBG Estradiol Prolactin - fasting

Thyroid, the full panel

TSH Free T4 Free T3 Reverse T3 TPO antibodies Thyroglobulin antibodies

Confirming the protocol is landing

Vitamin D 25-OH Zinc Homocysteine

Metabolic and inflammatory layer

Fasting insulin HbA1c hs-CRP

Prolactin once, fasting, and repeated fasting if elevated. TSH target at or below 2.5 mIU/L, read alongside the free hormones and the antibodies rather than on its own.

Take this with you

Questions for your provider

We have been trying for a while - can we run or repeat a semen analysis, and should I see a fertility urologist?
My FSH is elevated and/or my testosterone is low - is this a testicular or a brain-side cause? If testosterone is low and conception is the goal, can we use approaches that raise my own production - a SERM such as enclomiphene, or hCG - rather than replacement testosterone, which would suppress sperm?
I am currently on testosterone replacement and we want children. What does the transition look like, over what timeline, and what can we do so I do not feel terrible during it?
Should I be evaluated for a varicocele?
My prolactin is elevated - should we repeat it fasting and evaluate the pituitary?
My TSH or thyroid antibodies suggest thyroid involvement - should we address it before conceiving, given the effect on motility?
My standard analysis looks unremarkable and we still are not conceiving - is DNA fragmentation testing worth adding?

Where this leaves you

The manufacturing line runs on a fixed schedule, and almost everything practical in this guide follows from that. It means a bad result is a report on a window that has already closed rather than a statement about you, and it means the levers you pull now are pulling on a batch that does not exist yet.

It also means the thing worth doing is the thing that gets done at least three months out, and the thing most worth doing today is the semen analysis nobody has asked you for. Both partners get the workup.

This guide is educational and is not medical advice, diagnosis, or treatment. It does not replace the judgment of a licensed clinician who knows your history and your labs. Fertility care, hormone therapy, and the management of testosterone replacement are clinical decisions that carry real risks and require monitoring - nothing here is an instruction to start, stop, or change a prescribed medication on your own. Supplements can interact with medications and conditions; review any protocol with your clinician before starting, particularly if you are managing a medical condition or taking prescription medication. Biomarker panels and reference limits listed here are illustrative, not exhaustive, and reference ranges vary by assay and laboratory. Merlin may earn a commission on products purchased through the Fullscript link here.

Read this against your own results. Bring what you have - any lab, any year, any provider. Your first month reads your results together, every result against every other.

Start your first month - $35

If you don't feel the value of Merlin after paying for your first month, tell us and we'll refund you in full. Monthly Core, once per person, by email within 30 days. The terms →

No results yet? Start with the questions, free.

Work with a practitioner. Some pictures want a second set of eyes and a plan you did not have to build yourself.

Start a conversation

~ Your health data is never used to train AI. ~